Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.048 | 0.7 |
mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.02 | 0.7 |